This report analyzes the worldwide markets for Biochips in US$ Million by the following Product Segments: DNA Chips, Protein Chips, and Lab Chips. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America. The report profiles 77 companies including many key and niche players such as Affymetrix Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Caliper Life Sciences, Inc., Cepheid Inc., Fluidigm Corporation, GE Healthcare Ltd., Illumina, Inc., Life Technologies Corporation, Ocimum Biosolutions Ltd., Takara Bio, Inc., Clontech Laboratories, Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

TABLE OF CONTENTS

BIOCHIPS 									MCP-1026
A GLOBAL STRATEGIC BUSINESS REPORT	



                                            CONTENTS


  I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
      Study Reliability and Reporting Limitations                       I-1
      Disclaimers                                                       I-2
      Data Interpretation & Reporting Level                             I-3
       Quantitative Techniques & Analytics                              I-3
      Product Definitions and Scope of Study                            I-3
       A. DNA Chips                                                     I-3
       B. Protein Chips                                                 I-4
       C. Lab Chips                                                     I-4


 II. EXECUTIVE SUMMARY

  1. INDUSTRY OVERVIEW                                                  II-1
      A Primer                                                          II-1
      Recession Dries Up Funds for Biotech Firms                        II-1
      Promising Biochips Promote Biological Research                    II-2
       Key Forces Driving the Industry                                  II-3
       DNA Chips Lead the Application Front                             II-3
       Protein Biochips - Set for Robust Expansion                      II-3
       Lab-on-a-Chips: Fusion of Nanotechnology & Genetic Engineering   II-4
      Industry Challenges                                               II-4
       Standardization: A Key Challenge                                 II-4
       Price Dearness Pauses Biochips Growth                            II-5

  2. MARKET DYNAMICS                                                    II-6
      Current Approaches to Biochips                                    II-6
      The Business of Biochips                                          II-6
      Technological Differentiation in Demand                           II-7
      Focus on Highly Intelligent Diagnostic Systems                    II-7
      Scalability & Pricing - Focus Areas                               II-7
      Biochips: Expanding Role in Diagnostic Medicine                   II-8
      Advancements in Biochip Technology                                II-8
       Biochip Technology Boosts Personalised Medicine                  II-9
       Biochip Technology Spreads beyond Pharma Industry                II-9
       Proteomics “Chip” into Biochip Technology                        II-10
       Towards Increasing Minaturization                                II-10
      Technological Trends                                              II-10
       Sensitivity                                                      II-10
       Microfabrication                                                 II-10
       Density                                                          II-11
       Integrated Chips                                                 II-11
       Patent Trends                                                    II-11
        Table 1: Number of Lab-on-a-Chip Patents (includes
        corresponding Graph/Chart)                                      II-11

        Table 2: % of Lab-on-a-Chip Patent Documents by
        Country/Authority of Origin (January 2008 - April 2009)
        (includes corresponding Graph/Chart)                            II-12

        Table 3: Number of Lab-on-a-Chip Documents by Patent
        Assignees (January 2008 - April 2009) (includes
        corresponding Graph/Chart)                                      II-12
        Patent Applications                                             II-13

  3. COMPETITION                                                        II-14
      Industry Structure                                                II-14
      Major Participants                                                II-14
       Affymetrix: A Major Market Player                                II-14
      Growing Partnerships between Pharma and Biotech Companies         II-14
      Tech Giants Join the Biochip Fray                                 II-15

  4. PRODUCT OVERVIEW                                                   II-17
      Biochips - Complex Blend of Biochemistry and Electronics          II-17
      Historical Perspective                                            II-17
      Lab-on-a-chip: An Enabled Technology                              II-19
      Utility                                                           II-19
      Evolution and Segmentation                                        II-19
      Differing Perspectives                                            II-19
      Classification of Biochips                                        II-20
       Need for Biochips                                                II-21
        Manufacturing Systems Used in Biochip Manufacture               II-21
      Working of a Biochip                                              II-22
       DNA Transcription & Translation Through A Biochip                II-22
      A Functional Model                                                II-22
      Cocktail of Disparate Technically Specialized Applications        II-23
       Biochips: By-product of Multi-disciplinary Sciences              II-23
       Nanotechnology                                                   II-23
       BioMEMS                                                          II-23
       Microfluidics                                                    II-24
       Micro Total Analysis System                                      II-24

  5. BIOCHIP AND MICROARRAY CONSTRUCTION                                II-26
      Chip Architecture                                                 II-26
       Essence of a Biochip                                             II-26
       Concept of a Microarray                                          II-26
       Microarray Modules                                               II-26
      High Degree of Automation Spurs Biochips Use                      II-27
       Microfabrication Technology in Biochips made from Polymer and
        Plastics                                                        II-27
       Micro-optics in Biochips                                         II-28
       Liquid Handling Through Micro-Dispensers                         II-28
       Capillary Electrophoresis and Electrochemical Detectors          II-28
      Other Technologies                                                II-28
       Management of Bio-information                                    II-28
      Scanning                                                          II-29
      Microarray Database Management                                    II-29
      Classification of DNA Chips                                       II-29
       General Description of Spotted cDNA Microarrays                  II-29
       Spotted DNA Arrays                                               II-30
       Spotted cDNA Versus Spotted Oligonucleotide Arrays               II-30
       Limitations of Conventional cDNA Microarrays                     II-30
      Protein Biochips                                                  II-31
       General Applications of Protein Biochips                         II-31
       Challenges in the Design of a Protein Biochip                    II-32
      Limitations of Protein Chip Technology                            II-32
      Concluding Remarks for Protein Biochips                           II-33

  6. APPLICATIONS OF BIOCHIPS                                           II-34
      Biochip Uses                                                      II-35
      Pharmaceutical Investigation                                      II-35
       Medical Diagnostics                                              II-35
        Advantages of Biosensor Chip Technology                         II-36
       Forensics                                                        II-36
       Transplantation Screening                                        II-36
       Identity Testing                                                 II-36
       Water and Environmental Testing                                  II-37
       Food Industry                                                    II-37

  7. PRODUCT INNOVATIONS/INTRODUCTIONS                                  II-38
      Randox Launches Evidence Evolution Analyzer                       II-38
      South Korea Develops Instant Microfluidic Biochip                 II-38
      Fluidigm Introduces Reusable FR48.48 Dynamic Array™ IFC           II-38
      Cellix Introduces Vena4Y™ and Vena4Y2™ Biochips                   II-38
      Agilent Technologies Unveils Workflow HPLC-Chip                   II-39
      Febit Holding Introduces First Human Cancer Biochip               II-39
      Blue4Green Rolls Out Lab-on-a-chip Solution                       II-40
      Randox Laboratories Unveils Biochip Arrays                        II-40
      Randox Laboratories Introduces Evidence Investigator              II-40
      Randox Unveils Innovative DoA Biochips for Rapid Drug Screening   II-41
      Randox Launches Revolutionary Biochip Analyser for Multiple
       Cardiac Testing                                                  II-41
      Febit Unveils Biochip for DNA/RNA Detection and Enrichment on
       Mouse Genome                                                     II-42
      Veredus Laboratories Launches Portable Test Kit for H1N1 Flu      II-42
      Randox Develops Multi Marker Cardiac Biochip Array for MI
       Diagnosis                                                        II-42
      VigeneTech and CapitalBio Launch Completely Integrated
       Microarray Solution Platform                                     II-43

  8. PRODUCT INNOVATIONS/INTRODUCTIONS - A HISTORIC PERSPECTIVE BUILDER II-44
      Randox Introduces New Biochip Array for CAMs Testing              II-44
      Cellix Announces Global Launch of VenaEC Biochip                  II-44
      Decision Biomarkers Rolls Out AVANTRA™ Biomarker Workstation
       System                                                           II-44
      Osaka Develops Biocompatible Monomers for Biochips                II-45
      Iris BioTechnologies Launches New Nano-Biochip                    II-45
      Affymetrix Introduces Complete Cytogenetic Solution               II-45
      Agilent Unveils 244K CGH Micro-Array                              II-46
      Randox Unveils World’s First Protein Biochip                      II-46
      Randox Introduces Thyroid Array Biochip                           II-46
      Sigma Launches ChIP Kit                                           II-46
      Randox Develops Biochip for Synthetic Steroids                    II-47
      US and Czech Scientists to Develop Biochips for Detecting Cancer  II-47
      Manchester University Researchers Develop New Protein Chips
       Manufacturing Procedure                                          II-47
      febit Introduces New Geniom Biochip                               II-48
      Agilent Introduces Additions to the HPLC-Chip Line for Proteomics II-49
      Progenika Develops BLOODchip                                      II-49
      Roche Introduces Gene Expression Services and Arrays              II-49
      Stratos Biosystems Develops New EC-Affinity Biochips              II-50
      Affymetrix Unveils Affymetrix GeneChip Command Console Software   II-50
      Affymetrix Introduces GeneChip Mouse and Rat Gene 1.0 ST Arrays   II-50
      Affymetrix Unveils Genome-Wide Human SNP Array 6.0                II-51
      Caliper Life Sciences Launches High Throughput RNA Assay          II-51
      Applied Biosystems Unveils DNA Tools                              II-52
      febit Launches Geniom RT Analyzer                                 II-52
      Austrian Research Center Develops New Biochip Surface             II-52
      Researchers Develop Biochips to Eliminate Animal Testing          II-53
      Progenika Biopharma Launches IBD DNA                              II-53
      Bioident Develops New Lab-on-a-Chip Nanotiter Plate Prototype     II-53
      Ilochip and University of Denmark Develop a Biochip for Faster
       Bird Flu Detection                                               II-54
      CombiMatrix Develops a Biochip for Leukemia Analysis              II-54
      Affymetrix Launches New Tiling Arrays for Mapping Whole-Genome
       Transcript                                                       II-54
      Roche Plans to Launch AmpliChip in Japan                          II-54
      Caliper Life Sciences Unveils Desktop Profiler                    II-55
      Massachusetts Institute of Technology Develops Portable Lab on
       a Chip                                                           II-55
      Optical Device to Develop Lab-on-a-Chip                           II-55
      Agilent Launches Five New HPLC Chips                              II-56
      Protagen AG Launches New Protein Biochips                         II-56
      Fluidigm Releases the 8.96 TOPAZ Screening Chip                   II-56
      Affymetrix Releases Chip-on-Chip Array                            II-56
      DNA Chip Research Launches High Sensitivity DNA Chip              II-56
      DNA Chip Research and HitachiSoft Unveils AceGene                 II-56

  9. RECENT INDUSTRY ACTIVITY                                           II-57
      PerkinElmer Acquires Caliper Life Sciences                        II-57
      Philips and bioMerieux to Produce Biochips for Cardiovascular
       Assays                                                           II-57
      Roche Diagnostics and CapitalBio to Sign MOU                      II-57
      SVTC Partners with TSMC to Commercialize New Technologies         II-58
      HORIBA Jobin Yvon Takes Over GenOptics                            II-58
      GWC Technologies to Receive $100,000 Federal Grant                II-58
      febit to Receive Funds for Biomarker Project                      II-59
      Researchers Assess TB-Biochip MDR Test System                     II-59
      IBM to Use DNA Chip for Developing Personalized Medicine          II-59

  10. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-60
      Invitrogen and Applied Biosystems Merge to Form Life
       Technologies Corporation                                         II-60
      China Medical Technologies Signs Agreement with Molecular
       Diagnostics Technologies                                         II-60
      DNA Chip Acquires HuBit’s Gene Analysis Business                  II-60
      Affymetrix Acquires USB                                           II-61
      Roche NimbleGen Forms Alliance with BioDiscovery to Provide
       CGH Solutions                                                    II-61
      Illumina Announces Partnership with Genpathway for ChIP
       Sequencing Services                                              II-61
      Jiangsu and IMDi Diagnosis to Establish Joint Venture             II-62
      Plexera Biosciences Enters into an Option Deal with Auguron       II-62
      Affymetrix and Avesthagen Enter into an Agreement                 II-63
      Roche NimbleGen and Affymetrix Announce Expansion of License
       Agreement                                                        II-63
      Proteomika and Auguron Biosciences Ink Option Agreement           II-63
      Gentel Biosciences and Eppendorf Enter into Global License
       Agreement                                                        II-64
      GATC Biotech Establishes New Subsidiary                           II-64
      Procognia Spins off Sense Proteomic                               II-65
      Johns Hopkins University Purchases MassARRAY System               II-65
      Yale University Purchases MassARRAY System                        II-65
      Korea’s NIH Extends KARE Project with Affymetrix Technology       II-65
      febit Obtains US Patent for Hybselect, a Microfluidic
       Extraction Method                                                II-66
      Atotech Enters into Research Collaboration with University of
       Albany                                                           II-66
      CapitalBio and Beijing National Engineering Research Center
       Develop New Biochip Testing System                               II-66
      Roche Takes Over NimbleGen                                        II-67
      GenTel BioSciences Acquires Protein Chip Platform Assets of GSK   II-67
      Advanced Liquid Logic Acquires Nanolytics                         II-68
      Applied Microarrays Acquires Select GE Healthcare’s Assets        II-68
      Canon, Toshiba and Other Companies to Join Hands for Biochips     II-69
      BioChip Innovations Signs Research Collaboration Agreement
       with IME                                                         II-69
      Protagen Enters into a Partnership to Develop Antibodies          II-69
      Spanish Society of Rheumatology Enters into Collaboration with
       Progenika                                                        II-70
      Affymetrix and Partners Healthcare Extend Collaboration           II-70
      Agencourt, NuGEN and Affymetrix Clinical Services Collaborate     II-70
      Affymetrix Inks Licensing Agreement with Empire Genomics          II-71
      Caliper Enters into a Licensing Agreement with Monogram
       Biosciences                                                      II-71
      Affymetrix and IPSOGEN Sign Agreement                             II-72
      bioMérieux and NuGEN Enter into Supply and Cross-License
       Agreement                                                        II-72
      VWR and CapitalBio Enter into a Distribution Agreement            II-73
      C3B Bags Contract from Department of Defense to Develop an
       Implantable Biochip                                              II-73
      UCL Subsidiary and Roche Diagnostics Ink Licensing Deal           II-73
      Affymetrix Establishes the European Cytogenetic Research
       Initiative                                                       II-74
      Fluidigm Establishes New Development Center                       II-74
      Daiichi Pure Chemicals Applies for Approval to Market DNA
       Micro-array                                                      II-74
      GE Healthcare Snaps Up Biacore                                    II-75
      Bio-Rad Acquires Ciphergen’s Life Science Research Business       II-75
      Sysmex to Form Partnership with Affymetrix                        II-75
      Daiichi, Toshiba Hokuto and Toshiba Join Hands                    II-75
      Affymetrix Collaborates with Zhejiang California Nanosystem
       Institute                                                        II-76
      Merck Sharp & Dohme and Shanghai Biochip Enter into Co-
       operation Agreement                                              II-76
      Toshiba Signs Licensing Agreement with Antara BioSciences         II-77
      MUSC Signs LOI with Lumera                                        II-77
      AVIVA Inks Agreement with Japan’s Cosmo Bio                       II-77
      Lumera Signs Collaborative Agreement with Harvard Medical School  II-77
      Whatman Receives CE Mark for CombiChip                            II-78
      IDIBAPS Led Project Receives Approval from European Union         II-78
      Toray to Establish DNA Chip Business                              II-79
      Protagen Forays into the US Market                                II-79
      Biacore Expands Operations into Chinese Market                    II-79
      Nisshinbo to Replace Glass with Resin in DNA Production           II-79

  11. FOCUS ON SELECT GLOBAL PLAYERS                                    II-80
      Affymetrix Inc (US)                                               II-80
      Agilent Technologies, Inc. (US)                                   II-80
      Bio-Rad Laboratories, Inc. (US)                                   II-81
      Caliper Life Sciences, Inc. (US)                                  II-81
      Cepheid Inc. (US)                                                 II-81
      Fluidigm Corporation (US)                                         II-82
      GE Healthcare Ltd. (UK)                                           II-82
      Illumina, Inc. (US)                                               II-82
      Life Technologies Corporation (US)                                II-83
      Ocimum Biosolutions Ltd. (India)                                  II-83
      Takara Bio, Inc. (Japan)                                          II-84
       Clontech Laboratories, Inc. (US)                                 II-84
      Zyomyx, Inc. (US)                                                 II-84

  12. GLOBAL MARKET PERSPECTIVE                                         II-85
      Table 4: World Recent Past, Current & Future Analysis for
      Biochips by Geographic Region - US, Canada, Japan, Europe, and
      Rest of World Markets Independently Analyzed with Annual Sales
      Figures in US$ Million for Years 2009 through 2017 (includes
      corresponding Graph/Chart)                                        II-85

      Table 5: World Historic Review for Biochips by Geographic
      Region - US, Canada, Japan, Europe, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2003 through 2008 (includes corresponding
      Graph/Chart)                                                      II-86

      Table 6: World 15-Year Perspective for Biochips by Geographic
      Region - Percentage Breakdown of Dollar Sales for US, Canada,
      Japan, Europe, and Rest of World Markets for Years 2003, 2011
      & 2017 (includes corresponding Graph/Chart)                       II-87

      Table 7: World Recent Past, Current & Future Analysis for DNA
      Chips by Geographic Region - US, Canada, Japan, Europe, and
      Rest of World Markets Independently Analyzed with Annual Sales
      Figures in US$ Million for Years 2009 through 2017 (includes
      corresponding Graph/Chart)                                        II-88

      Table 8: World Historic Review for DNA Chips by Geographic
      Region - US, Canada, Japan, Europe, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2003 through 2008 (includes corresponding
      Graph/Chart)                                                      II-89

      Table 9: World 15-Year Perspective for DNA Chips by Geographic
      Region - Percentage Breakdown of Dollar Sales for US, Canada,
      Japan, Europe, and Rest of World Markets for Years 2003, 
      2011 & 2017 (includes corresponding Graph/Chart)                  II-90

      Table 10: World Recent Past, Current & Future Analysis for
      Protein Chips by Geographic Region - US, Canada, Japan,
      Europe, and Rest of World Markets Independently Analyzed with
      Annual Sales Figures in US$ Million for Years 2009 through
      2017 (includes corresponding Graph/Chart)                         II-91

      Table 11: World Historic Review for Protein Chips by
      Geographic Region - US, Canada, Japan, Europe, and Rest of
      World Markets Independently Analyzed with Annual Sales Figures
      in US$ Million for Years 2003 through 2008 (includes
      corresponding Graph/Chart)                                        II-92

      Table 12: World 15-Year Perspective for Protein Chips by
      Geographic Region - Percentage Breakdown of Dollar Sales for
      US, Canada, Japan, Europe, and Rest of World Markets for Years
      2003, 2011 & 2017 (includes corresponding Graph/Chart)            II-93

      Table 13: World Recent Past, Current & Future Analysis for Lab
      Chips by Geographic Region - US, Canada, Japan, Europe, and
      Rest of World Markets Independently Analyzed with Annual Sales
      Figures in US$ Million for Years 2009 through 2017 (includes
      corresponding Graph/Chart)                                        II-94

      Table 14: World Historic Review for Lab Chips by Geographic
      Region - US, Canada, Japan, Europe, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2003 through 2008 (includes corresponding
      Graph/Chart)                                                      II-95

      Table 15: World 15-Year Perspective for Lab Chips by
      Geographic Region - Percentage Breakdown of Dollar Sales for
      US, Canada, Japan, Europe, and Rest of World Markets for Years
      2003, 2011 & 2017 (includes corresponding Graph/Chart)            II-96


 III. MARKET

  1. THE UNITED STATES                                                  III-1
      A.Market Analysis                                                 III-1
        An Insight into Biochip Products & Services Market              III-1
         Rapid Growth for Protein, Lab Biochips                         III-1
         Robust Demand for Biochip Reagents and Consumables             III-2
         Growth Prospects for Biochip Instruments & Software            III-2
         Potential for Biochip Service Revenues                         III-2
         Biochip Product & Service Demand Among Biotech Companies       III-3
        Biochip Products and Services Demand in Life Science
         Research Applications                                          III-3
         Laboratory Chips Market                                        III-4
          Table 16: US Laboratory Chip Market by Application (2007 &
          2015P): Percentage Share Breakdown of Revenues for Life
          Science Research, Forensic Medicine, In Vitro Diagnostic
          Testing, Drugs-of- Abuse Testing, Disease Management, and
          Others (includes corresponding Graph/Chart)                   III-4
        Competitive Landscape                                           III-5
         Table 17: Leading Players in the US Biochip Products and
         Services Market (2007): Percentage Share Breakdown of
         Revenues for Illumina, Affymetrix, Applied Biosystems,
         GE/Amersham, Invitrogen, Bio-Rad, Caliper Life Science,
         Cepheid, Agilent Techs, Beckman Coulter, and Others
         (includes corresponding Graph/Chart)                           III-5
      B.Market Analytics                                                III-6
        Table 18: US Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Chips, Protein Chips and
        Lab Chips Markets Independently Analyzed with Annual Sales
        Figures in US$ Million for Years 2009 through 2017 (includes
        corresponding Graph/Chart)                                      III-6

        Table 19: US Historic Review for Biochips by Product Segment
        - DNA Chips, Protein Chips and Lab Chips Markets
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2003 through 2008 (includes corresponding
        Graph/Chart)                                                    III-7

        Table 20: US 15-Year Perspective for Biochips by Product
        Segment - Percentage Breakdown of Dollar Sales for DNA
        Chips, Protein Chips and Lab Chips Markets for Years 2003,
        2011 & 2017 (includes corresponding Graph/Chart)                III-8

  2. CANADA                                                             III-9
       Market Analytics                                                 III-9
        Table 21: Canadian Recent Past, Current & Future Analysis
        for Biochips by Product Segment - DNA Chips, Protein Chips
        and Lab Chips Markets Independently Analyzed with Annual
        Sales Figures in US$ Million for Years 2009 through 2017
        (includes corresponding Graph/Chart)                            III-9

        Table 22: Canadian Historic Review for Biochips by Product
        Segment - DNA Chips, Protein Chips and Lab Chips Markets
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2003 through 2008 (includes corresponding
        Graph/Chart)                                                    III-10

        Table 23: Canadian 15-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Chips, Protein Chips and Lab Chips Markets for Years
        2003, 2011 & 2017 (includes corresponding Graph/Chart)          III-11

  3. JAPAN                                                              III-12
      A.Market Analysis                                                 III-12
        ICAN™ Technology for Large-Scale Production of DNA Fragments    III-12
      B.Market Analytics                                                III-13
        Table 24: Japanese Recent Past, Current & Future Analysis
        for Biochips by Product Segment - DNA Chips, Protein Chips
        and Lab Chips Markets Independently Analyzed with Annual
        Sales Figures in US$ Million for Years 2009 through 2017
        (includes corresponding Graph/Chart)                            III-13

        Table 25: Japanese Historic Review for Biochips by Product
        Segment - DNA Chips, Protein Chips and Lab Chips Markets
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2003 through 2008 (includes corresponding
        Graph/Chart)                                                    III-14

        Table 26: Japanese 15-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Chips, Protein Chips and Lab Chips Markets for Years
        2003, 2011 & 2017 (includes corresponding Graph/Chart)          III-15

  4. EUROPE                                                             III-16
      A.Market Analysis                                                 III-16
        Lab-on-chip Market in Europe                                    III-16
        European Advancements Shape Diagnostic Procedures               III-17
      B.Market Analytics                                                III-17
        Table 27: European Recent Past, Current & Future Analysis
        for Biochips by Geographic Region - France, Germany, UK, and
        Rest of Europe Markets Independently Analyzed with Annual
        Sales Figures in US$ Million for Years 2009 through 2017
        (includes corresponding Graph/Chart)                            III-17

        Table 28: European Historic Review for Biochips by
        Geographic Region - France, Germany, UK, and Rest of Europe
        Markets Independently Analyzed with Annual Sales Figures in
        US$ Million for Years 2003 through 2008 (includes
        corresponding Graph/Chart)                                      III-18

        Table 29: European 15-Year Perspective for Biochips by
        Geographic Region - Percentage Breakdown of Dollar Sales for
        France, Germany, UK, and Rest of Europe Markets for Years
        2003, 2011 & 2017 (includes corresponding Graph/Chart)          III-19

        Table 30: European Recent Past, Current & Future Analysis
        for Biochips by Product Segment - DNA Chips, Protein Chips
        and Lab Chips Markets Independently Analyzed with Annual
        Sales Figures in US$ Million for Years 2009 through 2017
        (includes corresponding Graph/Chart)                            III-20

        Table 31: European Historic Review for Biochips by Product
        Segment - DNA Chips, Protein Chips and Lab Chips Markets
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2003 through 2008 (includes corresponding
        Graph/Chart)                                                    III-21

        Table 32: European 15-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Chips, Protein Chips and Lab Chips Markets for Years
        2003, 2011 & 2017 (includes corresponding Graph/Chart)          III-22

  4a. FRANCE                                                            III-23
       Market Analytics                                                 III-23
        Table 33: French Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Chips, Protein Chips and
        Lab Chips Markets Independently Analyzed with Annual Sales
        Figures in US$ Million for Years 2009 through 2017 (includes
        corresponding Graph/Chart)                                      III-23

        Table 34: French Historic Review for Biochips by Product
        Segment - DNA Chips, Protein Chips and Lab Chips Markets
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2003 through 2008 (includes corresponding
        Graph/Chart)                                                    III-24

        Table 35: French 15-Year Perspective for Biochips by Product
        Segment - Percentage Breakdown of Dollar Sales for DNA
        Chips, Protein Chips and Lab Chips Markets for Years 2003,
        2011 & 2017 (includes corresponding Graph/Chart)                III-25

  4b. GERMANY                                                           III-26
      A.Market Analysis                                                 III-26
        Berlin, Brandenburg and Biochips                                III-26
      B.Market Analytics                                                III-27
        Table 36: German Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Chips, Protein Chips and
        Lab Chips Markets Independently Analyzed with Annual Sales
        Figures in US$ Million for Years 2009 through 2017 (includes
        corresponding Graph/Chart)                                      III-27

        Table 37: German Historic Review for Biochips by Product
        Segment - DNA Chips, Protein Chips and Lab Chips Markets
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2003 through 2008 (includes corresponding
        Graph/Chart)                                                    III-28

        Table 38: German 15-Year Perspective for Biochips by Product
        Segment - Percentage Breakdown of Dollar Sales for DNA
        Chips, Protein Chips and Lab Chips Markets for Years 2003,
        2011 & 2017 (includes corresponding Graph/Chart)                III-29

  4c. THE UNITED KINGDOM                                                III-30
       Market Analytics                                                 III-30
        Table 39: UK Recent Past, Current & Future Analysis for
        Biochips by Product Segments- DNA Chips, Protein Chips and
        Lab Chips Markets Independently Analyzed with Annual Sales
        Figures in US$ Million for Years 2009 through 2017 (includes
        corresponding Graph/Chart)                                      III-30

        Table 40: UK Historic Review for Biochips by Product Segment-
        DNA Chips, Protein Chips and Lab Chips Markets
        Independently Analyzed with Annual Sales Figures in US$
        Million for Years 2003 through 2008 (includes corresponding
        Graph/Chart)                                                    III-31

        Table 41: UK 15-Year Perspective for Biochips by Product
        Segment - Percentage Breakdown of Dollar Sales for DNA
        Chips, Protein Chips and Lab Chips Markets for Years 2003,
        2011 & 2017 (includes corresponding Graph/Chart)                III-32

  4d. REST OF EUROPE                                                    III-33
       Market Analysis                                                  III-33
        Table 42: Rest of Europe Recent Past, Current & Future
        Analysis for Biochips by Product Segment - DNA Chips,
        Protein Chips and Lab Chips Markets Independently Analyzed
        with Annual Sales Figures in US$ Million for Years 2009
        through 2017 (includes corresponding Graph/Chart)               III-33

        Table 43: Rest of Europe Historic Review for Biochips by
        Product Segment - DNA Chips, Protein Chips and Lab Chips
        Markets Independently Analyzed with Annual Sales Figures in
        US$ Million for Years 2003 through 2008 (includes
        corresponding Graph/Chart)                                      III-34

        Table 44: Rest of Europe 15-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Chips, Protein Chips and Lab Chips Markets for Years
        2003, 2011 & 2017 (includes corresponding Graph/Chart)          III-35

  5. REST OF WORLD                                                      III-36
      A.Market Analysis                                                 III-36
        China                                                           III-36
         Basic Environment and Commercial Development                   III-36
         Biochip Research Institutes                                    III-37
        Taiwan                                                          III-37
         Taiwan Pursues Promise of Biochip Sector                       III-37
         International Advantage Sought                                 III-37
      B.Market Analytics                                                III-38
        Table 45: Rest of World Recent Past, Current & Future
        Analysis for Biochips by Product Segment - DNA Chips,
        Protein Chips and Lab Chips Markets Independently Analyzed
        with Annual Sales Figures in US$ Million for Years 2009
        through 2017 (includes corresponding Graph/Chart)               III-38

        Table 46: Rest of World Historic Review for Biochips by
        Product Segment - DNA Chips, Protein Chips and Lab Chips
        Markets Independently Analyzed with Annual Sales Figures in
        US$ Million for Years 2003 through 2008 (includes
        corresponding Graph/Chart)                                      III-39

        Table 47: Rest of World 15-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Chips, Protein Chips and Lab Chips Markets for Years
        2003, 2011 & 2017 (includes corresponding Graph/Chart)          III-40


 IV. COMPETITIVE LANDSCAPE

     Total Companies Profiled: 77 (including Divisions/Subsidiaries - 87)

     ------------------------------------------
     Region/Country                     Players
     ------------------------------------------
     The United States                     40
     Japan                                 14
     Europe                                25
      France                                4
      Germany                               8
      The United Kingdom                    4
      Spain                                 1
      Rest of Europe                        8
     Asia-Pacific (Excluding Japan)         8
     ------------------------------------------